← Leaderboards
Francesca Alvarez Calderon
University Of Colorado Denver
$142,364
Attributed
$142,364
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $42.2K · FY2010–13$50K$37.5K$25K$12.5K$0
'10
'11
'12
'13
Funding mix
By agency
NIH$142,364 · 1
By mechanism
F31$142,364 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Colorado Denver
Same institution · by research overlap
- Natalie J Serkova$3,493,253
Others in their field
Top investigators on “Abl Genes”
- Gregory H Reaman · National Childhood Cancer Foundation$153,791,973
- David Heimbrook · Leidos Biomedical Research, Inc.$93,473,364
- Robert L Comis · Frontier Sci &Technology Rsch Fdn, Inc$36,921,279
- Paul Warren Sternberg · California Institute Of Technology$32,568,656
- Stuart L Schreiber · Harvard University (Medical School)$30,193,983
- Bi-Cheng Wang · University Of Georgia (Uga)$28,779,344
Research focus
Abl GenesAcuteAldolase CBasic ScienceBcr-Abl Tyrosine KinaseCancer EtiologyCancer TherapyCell LineCell ProliferationCellsCell SurvivalChemotherapyChromosomes, Human, Pair 9Chronic Myeloid LeukemiaChronic PhaseCitric Acid CycleClinical PracticeClinical SciencesClinical TreatmentCombined Modality TherapyDesignDihydrolipoyllysine-Residue AcetyltransferaseDisciplineAbbreviations
Grant awards (4)
Exploiting altered glucose utilization in Bcr-Abl+ Leukemia$42,232
F31 · FY2013 · CA · contact PI
Exploiting altered glucose utilization in Bcr-Abl+ Leukemia$42,232
F31 · FY2012 · CA · contact PI
Exploiting altered glucose utilization in Bcr-Abl+ Leukemia$29,160
F31 · FY2011 · CA · contact PI
Exploiting altered glucose utilization in Bcr-Abl+ Leukemia$28,740
F31 · FY2010 · CA · contact PI